BR9706897A - Composições antifúngicas com biodisponibilidade aperfeiçoada. - Google Patents
Composições antifúngicas com biodisponibilidade aperfeiçoada.Info
- Publication number
- BR9706897A BR9706897A BR9706897-7A BR9706897A BR9706897A BR 9706897 A BR9706897 A BR 9706897A BR 9706897 A BR9706897 A BR 9706897A BR 9706897 A BR9706897 A BR 9706897A
- Authority
- BR
- Brazil
- Prior art keywords
- improved bioavailability
- day
- compositions
- antifungal compositions
- mixture
- Prior art date
Links
- 239000012871 anti-fungal composition Substances 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 3
- 241000124008 Mammalia Species 0.000 abstract 2
- VHVPQPYKVGDNFY-DFMJLFEVSA-N 2-[(2r)-butan-2-yl]-4-[4-[4-[4-[[(2r,4s)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one Chemical compound O=C1N([C@H](C)CC)N=CN1C1=CC=C(N2CCN(CC2)C=2C=CC(OC[C@@H]3O[C@](CN4N=CN=C4)(OC3)C=3C(=CC(Cl)=CC=3)Cl)=CC=2)C=C1 VHVPQPYKVGDNFY-DFMJLFEVSA-N 0.000 abstract 1
- 206010017533 Fungal infection Diseases 0.000 abstract 1
- 208000031888 Mycoses Diseases 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 238000001125 extrusion Methods 0.000 abstract 1
- 229960004130 itraconazole Drugs 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229920003169 water-soluble polymer Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96201430 | 1996-05-20 | ||
EP97200698 | 1997-03-07 | ||
PCT/EP1997/002507 WO1997044014A1 (en) | 1996-05-20 | 1997-05-12 | Antifungal compositions with improved bioavailability |
Publications (2)
Publication Number | Publication Date |
---|---|
BR9706897A true BR9706897A (pt) | 1999-08-31 |
BR9706897B1 BR9706897B1 (pt) | 2010-09-21 |
Family
ID=26142825
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI9706897-7A BR9706897B1 (pt) | 1996-05-20 | 1997-05-12 | forma de dosagem farmacêutica. |
Country Status (34)
Country | Link |
---|---|
US (4) | US6509038B2 (pt) |
EP (1) | EP0904060B1 (pt) |
JP (1) | JP3391801B2 (pt) |
KR (1) | KR19990044257A (pt) |
CN (1) | CN1165291C (pt) |
AR (1) | AR007195A1 (pt) |
AT (1) | ATE255883T1 (pt) |
AU (1) | AU722101B2 (pt) |
BG (1) | BG64368B1 (pt) |
BR (1) | BR9706897B1 (pt) |
CA (1) | CA2240161C (pt) |
CY (1) | CY2434B1 (pt) |
CZ (1) | CZ293841B6 (pt) |
DE (1) | DE69726729T2 (pt) |
DK (1) | DK0904060T3 (pt) |
EA (1) | EA001219B1 (pt) |
EE (1) | EE03902B1 (pt) |
ES (1) | ES2212810T3 (pt) |
HK (1) | HK1018002A1 (pt) |
HR (1) | HRP970270B1 (pt) |
HU (1) | HU227745B1 (pt) |
ID (1) | ID16926A (pt) |
IL (1) | IL124935A (pt) |
MX (1) | MX9805418A (pt) |
MY (1) | MY123827A (pt) |
NO (1) | NO320495B1 (pt) |
NZ (1) | NZ330739A (pt) |
PL (1) | PL188566B1 (pt) |
PT (1) | PT904060E (pt) |
SI (1) | SI0904060T1 (pt) |
SK (1) | SK284145B6 (pt) |
TR (1) | TR199801225T2 (pt) |
TW (1) | TW460282B (pt) |
WO (1) | WO1997044014A1 (pt) |
Families Citing this family (125)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR19990001564A (ko) * | 1997-06-16 | 1999-01-15 | 유충식 | 용해도를 개선한 아졸계 항진균제 및 이를 함유하는 제제 |
PT1039909E (pt) * | 1997-12-31 | 2003-02-28 | Choongwae Pharma Corp | Metodo de producao e composicao de uma preparacao oral de itraconazole |
KR100288890B1 (ko) * | 1997-12-31 | 2001-05-02 | 최현식 | 이트라코나졸 경구용 제제 및 그의 제조방법 |
KR100514330B1 (ko) * | 1997-12-31 | 2006-02-17 | 주식회사 중외제약 | 난용성 약물을 함유하는 코팅정 |
ES2157731B1 (es) * | 1998-07-21 | 2002-05-01 | Liconsa Liberacion Controlada | Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion. |
CA2362728C (en) * | 1999-03-24 | 2009-06-23 | Fmc Corporation | Improved aqueous solubility pharmaceutical formulations |
KR100331529B1 (ko) * | 1999-06-16 | 2002-04-06 | 민경윤 | 난용성 항진균제의 경구투여용 조성물 및 그의 제조 방법 |
ATE329579T1 (de) | 1999-11-12 | 2006-07-15 | Abbott Lab | Feste dispersion mit ritonavir, fenofibrat oder griseofulvin |
CA2396380C (en) * | 1999-12-23 | 2015-04-21 | David Hayes | Improved pharmaceutical compositions for poorly soluble drugs |
FR2803748A1 (fr) * | 2000-01-14 | 2001-07-20 | Ethypharm Lab Prod Ethiques | Composition d'itraconazole et procede de preparation |
DE10026698A1 (de) | 2000-05-30 | 2001-12-06 | Basf Ag | Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung |
KR100659644B1 (ko) * | 2000-06-22 | 2006-12-21 | 노파르티스 아게 | 고형 발사르탄 약제학적 조성물 |
DE10038571A1 (de) * | 2000-08-03 | 2002-02-14 | Knoll Ag | Zusammensetzungen und Dosierungsformen zur Anwendung in der Mundhöhle bei der Bhandlung von Mykosen |
US6884436B2 (en) * | 2000-12-22 | 2005-04-26 | Baxter International Inc. | Method for preparing submicron particle suspensions |
US6951656B2 (en) | 2000-12-22 | 2005-10-04 | Baxter International Inc. | Microprecipitation method for preparing submicron suspensions |
US9700866B2 (en) | 2000-12-22 | 2017-07-11 | Baxter International Inc. | Surfactant systems for delivery of organic compounds |
US8067032B2 (en) | 2000-12-22 | 2011-11-29 | Baxter International Inc. | Method for preparing submicron particles of antineoplastic agents |
US20050048126A1 (en) * | 2000-12-22 | 2005-03-03 | Barrett Rabinow | Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug |
PT1370543E (pt) | 2001-02-14 | 2007-02-28 | Tibotec Pharm Ltd | Inibidores de protease de vih 2-(amino-substituída)-benzotiazol-sulfonamida de largo espectro |
SK288232B6 (sk) | 2001-04-09 | 2014-11-04 | Tibotec Pharmaceuticals Ltd. | 2-(substituovaný amino)benzoxazolsulfónamidový derivát, jeho aplikácie ako liečiva, farmaceutická kompozícia s jeho obsahom a spôsob in vitro inhibície retrovírusovej replikácie |
DK1387842T3 (da) | 2001-05-11 | 2009-08-10 | Tibotec Pharm Ltd | Bredspektrede 2-amino-benzoxazolsulfonamid-HIV-protease-inhibitorer |
WO2002100407A1 (en) * | 2001-06-12 | 2002-12-19 | Smartrix Technologies Inc. | Itraconazole granulations: pharmaceutical formulations for oral administration and method of preparing same |
ATE444060T1 (de) | 2001-06-22 | 2009-10-15 | Pfizer Prod Inc | Pharmazeutische zusammensetzungen enthaltend dispersionen aus arzneistoffen und neutralen polymeren |
KR100455216B1 (ko) * | 2001-06-27 | 2004-11-09 | 한미약품 주식회사 | 난용성 항진균제의 경구투여용 조성물 및 이의 제조 방법 |
US7163700B2 (en) * | 2001-07-31 | 2007-01-16 | Capricorn Pharma, Inc. | Amorphous drug beads |
KR100438485B1 (ko) * | 2001-08-13 | 2004-07-09 | 한국디디에스제약 주식회사 | 아졸류 항진균제의 약제학적 조성물 |
US20060003012A9 (en) | 2001-09-26 | 2006-01-05 | Sean Brynjelsen | Preparation of submicron solid particle suspensions by sonication of multiphase systems |
BR0212833A (pt) | 2001-09-26 | 2004-10-13 | Baxter Int | Preparação de nanopartìculas de tamanho submìcron através de dispersão e de remoção de solvente ou de fase lìquida |
UA79248C2 (en) | 2001-11-09 | 2007-06-11 | Janssen Pharmaceutica Nv | Mandelate salts of substituted tetracyclic tetrahydrofuran derivatives |
CA2363376A1 (en) * | 2001-11-16 | 2003-05-16 | Bernard Charles Sherman | Solid pharmaceutical compositions for oral administration comprising itraconazole |
US6455557B1 (en) * | 2001-11-28 | 2002-09-24 | Elan Pharmaceuticals, Inc. | Method of reducing somnolence in patients treated with tizanidine |
US20040220240A1 (en) * | 2001-11-28 | 2004-11-04 | Pellegrini Cara A. | Method of increasing the extent of absorption of tizanidine |
MXPA04006201A (es) | 2001-12-21 | 2004-12-06 | Tibotec Pharm Ltd | Sulfonamidas que contienen fenilo sustituido con grupos heterociclicos, inhibidores de la proteasa del vih de amplio espectro. |
HRP20020124A2 (en) * | 2002-02-11 | 2003-10-31 | Pliva D D | Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping |
CN1943786A (zh) | 2002-02-28 | 2007-04-11 | 日本烟草产业株式会社 | 酯化合物及其医药用途 |
MY142238A (en) | 2002-03-12 | 2010-11-15 | Tibotec Pharm Ltd | Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors |
AU2003238074B2 (en) | 2002-05-17 | 2009-04-30 | Tibotec Pharmaceuticals Ltd. | Broadspectrum substituted benzisoxazole sulfonamide HIV protease inhibitors |
US7407670B2 (en) | 2002-07-04 | 2008-08-05 | Janssen Pharmaceutica, N.V. | Solid dispersions comprising two different polymer matrixes |
US7199148B2 (en) | 2002-08-14 | 2007-04-03 | Tibotec Pharmaceuticals Ltd | Broadspectrum substituted oxindole sulfonamide HIV protease inhibitors |
DK1551372T3 (en) | 2002-09-20 | 2018-07-23 | Alpharma Pharmaceuticals Llc | SEQUERATION SUBSTANCES AND RELATED COMPOSITIONS AND PROCEDURES |
US20040086567A1 (en) * | 2002-10-30 | 2004-05-06 | Pawan Seth | Bioequivalent composition of itraconazole and a hydrophilic polymer |
DE60312636T3 (de) * | 2003-01-14 | 2014-12-24 | Acino Pharma Ag | Bioaequivalente Zusammensetzung in der Form einer festen Dispersion enthaltend Itraconazol und ein hydrophiles Polymer |
JP4783278B2 (ja) * | 2003-02-03 | 2011-09-28 | ノバルティス アーゲー | 医薬製剤 |
EP1648467B1 (en) * | 2003-07-17 | 2018-03-21 | Janssen Sciences Ireland UC | Process for preparing particles containing an antiviral |
FR2857591B1 (fr) * | 2003-07-17 | 2007-11-02 | Ethypharm Sa | Particules comprenant un principe actif sous forme de co-precipite |
US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
WO2005021486A1 (ja) | 2003-08-29 | 2005-03-10 | Japan Tobacco Inc. | エステル誘導体及びその医薬用途 |
US20050058670A1 (en) * | 2003-09-09 | 2005-03-17 | Jong-Soo Woo | Oral itraconazole composition which is not affected by ingested food and process for preparing same |
MXPA06002780A (es) | 2003-09-11 | 2006-06-14 | Tibotec Pharm Ltd | Inhibidores de entrada del virus de vih. |
US20050118265A1 (en) * | 2003-11-28 | 2005-06-02 | Anandi Krishnan | Antifungal oral dosage forms and the methods for preparation |
GB0403098D0 (en) * | 2004-02-12 | 2004-03-17 | Euro Celtique Sa | Extrusion |
TWI350762B (en) * | 2004-02-12 | 2011-10-21 | Euro Celtique Sa | Particulates |
CA2558027A1 (en) * | 2004-03-03 | 2005-09-15 | Spherics, Inc. | Polymeric drug delivery system for hydrophobic drugs |
AR048650A1 (es) | 2004-05-04 | 2006-05-10 | Tibotec Pharm Ltd | Derivados de (1,10b-dihidro-2-(aminocarbonil-fenil)-5h-pirazolo[1,5 c][1,3]benzoxazin-5-il)fenil metanona como inhibidores de la replicacion viral del vih |
EP2422780A1 (en) | 2004-05-07 | 2012-02-29 | Sequoia Pharmaceuticals, Inc. | Resistance-repellent retroviral protease inhibitors |
EP1751165A1 (en) | 2004-05-17 | 2007-02-14 | Tibotec Pharmaceuticals Ltd. | 4-substituted 1,5-dihydro-pyrido(3,2-b)indol-2-ones |
AR049637A1 (es) | 2004-05-17 | 2006-08-23 | Tibotec Pharm Ltd | 1-fenil-1,5-dihidro-pirido[3,2-b]indol-2-onas sustituidas en las posiciones 6, 7, 8, 9 |
KR20070015608A (ko) | 2004-05-17 | 2007-02-05 | 티보텍 파마슈티칼즈 리미티드 | 1-헤테로사이클일-1,5-디히드로-피리도[3,2-b]인돌-2-온 |
WO2005117834A1 (en) * | 2004-05-27 | 2005-12-15 | Janssen Pharmaceutica N.V. | Solid dispersions of a basic drug compound and a polymer containing acidic groups |
KR20050119397A (ko) * | 2004-06-16 | 2005-12-21 | 보람제약주식회사 | 고상용해를 이용한 난용성 약물의 가용화 방법과 이를이용한 가용화 조성물 |
US20060030623A1 (en) * | 2004-07-16 | 2006-02-09 | Noboru Furukawa | Agent for the treatment or prevention of diabetes, obesity or arteriosclerosis |
KR100708974B1 (ko) * | 2004-07-19 | 2007-04-18 | 주식회사종근당 | 수용성 수지를 이용한 이트라코나졸 고체분산체 |
US20070281007A1 (en) * | 2004-08-27 | 2007-12-06 | Jacob Jules S | Mucoadhesive Oral Formulations of High Permeability, High Solubility Drugs |
US20060045865A1 (en) * | 2004-08-27 | 2006-03-02 | Spherics, Inc. | Controlled regional oral delivery |
US8101774B2 (en) | 2004-10-18 | 2012-01-24 | Japan Tobacco Inc. | Ester derivatives and medicinal use thereof |
CA2582767C (en) * | 2004-10-25 | 2011-05-24 | Japan Tobacco Inc. | Solid formulation with improved solubility and stability and method for producing said formulation |
EP1817008B1 (en) | 2004-11-09 | 2020-04-01 | Board of Regents, The University of Texas System | Stabilized hme composition with small drug particles |
WO2006073973A2 (en) | 2004-12-31 | 2006-07-13 | Reddy Us Therapeutics, Inc. | Novel benzylamine derivatives as cetp inhibitors |
US8604055B2 (en) | 2004-12-31 | 2013-12-10 | Dr. Reddy's Laboratories Ltd. | Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors |
AR056652A1 (es) | 2005-04-11 | 2007-10-17 | Tibotec Pharm Ltd | Derivados de (1,10-b dihidro-2-(aminoalquil-fenil) -5h-pirazolo (1,5-c) (1,3)benzoxazin-5-il) fenilmetanona y su uso en la fabricacion de un medicamento |
DE102005026755A1 (de) * | 2005-06-09 | 2006-12-14 | Basf Ag | Herstellung von festen Lösungen schwerlöslicher Wirkstoffe durch Kurzzeitüberhitzung und schnelle Trocknung |
PL1912626T3 (pl) * | 2005-08-08 | 2016-10-31 | Postaci użytkowe o polepszonej biodostępności | |
JP5538718B2 (ja) * | 2005-08-08 | 2014-07-02 | アボット ゲーエムベーハー ウント コンパニー カーゲー | 改善された生物学的利用能をもつイトラコナゾール組成物 |
JP5435946B2 (ja) * | 2005-08-22 | 2014-03-05 | ジョンズ ホプキンス ユニバーシティ | 疾患を処置するためのヘッジホッグ経路アンタゴニスト |
US7476405B2 (en) * | 2006-02-23 | 2009-01-13 | Iomedix Sleep International Srl | Compositions and methods for the induction and maintenance of quality sleep |
EP2004647A1 (en) | 2006-04-03 | 2008-12-24 | Tibotec Pharmaceuticals Ltd. | Hiv inhibiting 3,4-dihydro-imidazoý4,5-b¨pyridin-5-ones |
GB0607105D0 (en) * | 2006-04-10 | 2006-05-17 | Leuven K U Res & Dev | Enhancing solubility and dissolution rate of poorly soluble drugs |
MX2008016372A (es) | 2006-06-19 | 2009-05-28 | Alpharma Inc | Composiciones farmaceuticas. |
US20100003332A1 (en) * | 2006-07-27 | 2010-01-07 | Amorepacific Corporation | Process For Preparing Powder Comprising Nanoparticles of Sparingly Soluble Drug |
JP2010506833A (ja) * | 2006-10-11 | 2010-03-04 | アルファーマ,インコーポレイテッド | 医薬組成物 |
EP2155166A2 (en) * | 2007-05-11 | 2010-02-24 | F. Hoffmann-Roche AG | Pharmaceutical compositions for poorly soluble drugs |
US8426467B2 (en) | 2007-05-22 | 2013-04-23 | Baxter International Inc. | Colored esmolol concentrate |
US8722736B2 (en) | 2007-05-22 | 2014-05-13 | Baxter International Inc. | Multi-dose concentrate esmolol with benzyl alcohol |
WO2009026461A2 (en) * | 2007-08-21 | 2009-02-26 | Board Of Regents, The University Of Texas System | Thermo-kinetic mixing for pharmaceutical applications |
EP2471516A3 (en) | 2007-09-14 | 2012-12-26 | Wockhardt Limited | Rhein or diacerein compositions |
EP2520286A1 (en) | 2007-09-27 | 2012-11-07 | Wockhardt Limited | Pharmaceutical compositions of rhein or diacerein |
US20090130160A1 (en) * | 2007-11-21 | 2009-05-21 | Fiber Innovation Technology, Inc. | Fiber for wound dressing |
CA2707161C (en) | 2007-11-28 | 2016-08-16 | Sequoia Pharmaceuticals, Inc. | Compositions and methods for inhibiting cytochrome p450 2d6 |
CA2709905A1 (en) * | 2007-12-17 | 2009-06-25 | Alfred Liang | Abuse-resistant oxycodone composition |
US8623418B2 (en) | 2007-12-17 | 2014-01-07 | Alpharma Pharmaceuticals Llc | Pharmaceutical composition |
WO2009087410A2 (en) * | 2008-01-11 | 2009-07-16 | Cipla Limited | Solid pharmaceutical dosage form |
CA2716348C (en) | 2008-02-21 | 2017-04-04 | Sequoia Pharmaceuticals, Inc. | Diamide inhibitors of cytochrome p450 |
US8372432B2 (en) | 2008-03-11 | 2013-02-12 | Depomed, Inc. | Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic |
WO2009114648A1 (en) | 2008-03-11 | 2009-09-17 | Depomed Inc. | Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic |
AU2009236289B2 (en) * | 2008-04-15 | 2014-08-21 | Merck Sharp & Dohme Corp. | Oral pharmaceutical compositions in a solid dispersion comprising preferably posaconazole and HPMCAS |
EA200900145A1 (ru) * | 2008-12-31 | 2010-02-26 | Открытое Акционерное Общество "Верофарм" | Противогрибковое средство для вагинального применения |
CN101780046B (zh) * | 2009-01-16 | 2011-09-21 | 北京化工大学 | 一种伊曲康唑复合粉体及其制备方法 |
ES2453477T3 (es) | 2009-12-18 | 2014-04-07 | Frieslandcampina Nederland Holding B.V. | Composición de excipiente coprocesada para un comprimido, su preparación y uso |
US8597681B2 (en) | 2009-12-22 | 2013-12-03 | Mallinckrodt Llc | Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans |
US9198861B2 (en) | 2009-12-22 | 2015-12-01 | Mallinckrodt Llc | Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans |
ES2511145T3 (es) * | 2010-10-14 | 2014-10-22 | Abbott Gmbh & Co. Kg | Formulación de dispersión sólida de curcuminoides |
CN102068416A (zh) * | 2010-12-30 | 2011-05-25 | 安徽先求药业有限公司 | 一种含有伊曲康唑的口服固体制剂及其制备方法 |
WO2012110469A1 (en) | 2011-02-17 | 2012-08-23 | F. Hoffmann-La Roche Ag | A process for controlled crystallization of an active pharmaceutical ingredient from supercooled liquid state by hot melt extrusion |
US9050335B1 (en) | 2011-05-17 | 2015-06-09 | Mallinckrodt Llc | Pharmaceutical compositions for extended release of oxycodone and acetaminophen resulting in a quick onset and prolonged period of analgesia |
US8858963B1 (en) | 2011-05-17 | 2014-10-14 | Mallinckrodt Llc | Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia |
US8741885B1 (en) | 2011-05-17 | 2014-06-03 | Mallinckrodt Llc | Gastric retentive extended release pharmaceutical compositions |
JP2014521745A (ja) * | 2011-08-16 | 2014-08-28 | メルク・シャープ・アンド・ドーム・コーポレーション | 安定した非晶質分散体を調製するための無機マトリックスと有機ポリマーの組み合わせの使用 |
CA2845284C (en) | 2011-08-18 | 2018-03-06 | Dr. Reddy's Laboratories Ltd. | Substituted heterocyclic amine compounds as cholesteryl ester-transfer protein (cetp) inhibitors |
WO2013037396A1 (en) * | 2011-09-12 | 2013-03-21 | Bioneer A/S | Solution of polymer in api for a solid dosage form |
AU2012313971B2 (en) | 2011-09-27 | 2016-09-29 | Dr. Reddy's Laboratories, Ltd. | 5 - benzylaminomethyl - 6 - aminopyrazolo [3, 4 -b] pyridine derivatives as cholesteryl ester -transfer protein (CETP) inhibitors useful for the treatment of atherosclerosis |
US20140128431A1 (en) | 2012-04-03 | 2014-05-08 | Hoffmann-Laroche Inc. | Pharmaceutical composition with improved bioavailability, safety and tolerability |
EP2649989B1 (en) | 2012-04-13 | 2017-10-18 | King Saud University | Method for preparing a solid dispersion, solid dispersion obtained thereby and use thereof |
MX366829B (es) | 2012-06-21 | 2019-07-25 | Mayne Pharma Int Pty Ltd | Composiciones y formas de dosificacion de itraconazol y metodos de uso de las mismas. |
JP6235584B2 (ja) * | 2012-07-17 | 2017-11-22 | ダウ グローバル テクノロジーズ エルエルシー | 高置換ヒドロキシアルキルメチルセルロースを含む固体分散体 |
WO2014076568A2 (en) | 2012-11-19 | 2014-05-22 | Dr. Reddy's Laboratories Ltd. | Pharmaceutical compositions of cetp inhibitors |
AU2014210103B2 (en) | 2013-01-22 | 2018-09-06 | F. Hoffmann-La Roche Ag | Pharmaceutical composition with improved bioavailability |
CN104721827A (zh) * | 2013-12-18 | 2015-06-24 | 博瑞生物医药技术(苏州)有限公司 | 一种难溶性抗真菌药物固体分散体及其制备方法 |
CN105873954B (zh) * | 2014-01-16 | 2019-03-29 | 陶氏环球技术有限责任公司 | 用于3d打印的支撑材料 |
EP3307839B1 (en) * | 2015-06-09 | 2019-02-27 | Dow Global Technologies LLC | Support materials for 3d printing |
WO2017196712A1 (en) * | 2016-05-09 | 2017-11-16 | Dispersol Technologies, Llc | Improved drug formulations |
EP3675832A1 (en) | 2017-09-01 | 2020-07-08 | Jordan Sweden Medical and Sterilization Company | Fast self dispersible dosage forms of deferasirox |
CN109172532A (zh) * | 2018-10-24 | 2019-01-11 | 北京哈三联科技有限责任公司 | 一种伊曲康唑分散片及其制备方法和应用 |
BR112022003812A2 (pt) * | 2019-08-28 | 2022-05-24 | Lubrizol Advanced Mat Inc | Dispersão sólida amorfa, produto, e, métodos para administrar um ingrediente farmacêutico ativo a uma pessoa ou animal não humano e para formar uma dispersão sólida amorfa de um ingrediente farmacêutico ativo |
KR102266145B1 (ko) | 2019-09-26 | 2021-06-17 | 대봉엘에스 주식회사 | 비정질 에피나코나졸 고체 분산체 |
WO2023025672A1 (en) | 2021-08-25 | 2023-03-02 | Basf Se | Direct tableting auxiliary composition |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4218458A (en) * | 1978-06-23 | 1980-08-19 | Janssen Pharmaceutica, N.V. | Heterocyclic derivatives of (4-aryloxy-methyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles |
DE2966564D1 (en) | 1978-11-20 | 1984-02-23 | American Home Prod | Therapeutic compositions with enhanced bioavailability and process for their preparation |
JPS5879915A (ja) * | 1981-11-09 | 1983-05-13 | Nippon Soda Co Ltd | 棒状薬剤の製造方法 |
US4916134A (en) * | 1987-03-25 | 1990-04-10 | Janssen Pharmacuetica N.V. | 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]me]phenyl]-1-piperazinyl]phenyl]triazolones |
JPH0667840B2 (ja) * | 1988-11-30 | 1994-08-31 | 萬有製薬株式会社 | Nb―818の易吸収性製剤 |
US5028433A (en) | 1988-11-30 | 1991-07-02 | Banyu Pharmaceutical Co., Ltd. | Readily absorbable drug formulation of NB-818 |
DK469989D0 (da) * | 1989-09-22 | 1989-09-22 | Bukh Meditec | Farmaceutisk praeparat |
AU1537292A (en) * | 1991-04-16 | 1992-11-17 | Nippon Shinyaku Co. Ltd. | Method of manufacturing solid dispersion |
US5340591A (en) | 1992-01-24 | 1994-08-23 | Fujisawa Pharmaceutical Co., Ltd. | Method of producing a solid dispersion of the sparingly water-soluble drug, nilvadipine |
PT631578E (pt) * | 1992-03-18 | 2001-11-30 | Janssen Pharmaceutica Nv | Estereoisomeros de itraconazol e saperconazol |
DE4226753A1 (de) * | 1992-08-13 | 1994-02-17 | Basf Ag | Wirkstoffe enthaltende Zubereitungen in Form fester Teilchen |
PH30929A (en) | 1992-09-03 | 1997-12-23 | Janssen Pharmaceutica Nv | Beads having a core coated with an antifungal and a polymer. |
JP3413238B2 (ja) | 1993-03-31 | 2003-06-03 | オリンパス光学工業株式会社 | 位相制御膜構造体 |
JPH07112928A (ja) * | 1993-10-15 | 1995-05-02 | Freunt Ind Co Ltd | 難溶性薬物の溶解性改善方法およびそれにより得られた粒状薬剤 |
FR2722984B1 (fr) * | 1994-07-26 | 1996-10-18 | Effik Lab | Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees |
JP2948111B2 (ja) * | 1994-09-16 | 1999-09-13 | 塩野義製薬株式会社 | 経口投与用油性組成物 |
-
1997
- 1997-05-12 IL IL12493597A patent/IL124935A/en not_active IP Right Cessation
- 1997-05-12 CN CNB971917647A patent/CN1165291C/zh not_active Expired - Lifetime
- 1997-05-12 AU AU29562/97A patent/AU722101B2/en not_active Expired
- 1997-05-12 EE EE9800304A patent/EE03902B1/xx unknown
- 1997-05-12 EP EP97923915A patent/EP0904060B1/en not_active Expired - Lifetime
- 1997-05-12 EA EA199800571A patent/EA001219B1/ru not_active IP Right Cessation
- 1997-05-12 NZ NZ330739A patent/NZ330739A/xx not_active IP Right Cessation
- 1997-05-12 JP JP54150197A patent/JP3391801B2/ja not_active Expired - Lifetime
- 1997-05-12 SK SK848-98A patent/SK284145B6/sk not_active IP Right Cessation
- 1997-05-12 AT AT97923915T patent/ATE255883T1/de active
- 1997-05-12 US US09/194,480 patent/US6509038B2/en not_active Expired - Lifetime
- 1997-05-12 BR BRPI9706897-7A patent/BR9706897B1/pt not_active IP Right Cessation
- 1997-05-12 ES ES97923915T patent/ES2212810T3/es not_active Expired - Lifetime
- 1997-05-12 TR TR1998/01225T patent/TR199801225T2/xx unknown
- 1997-05-12 CA CA002240161A patent/CA2240161C/en not_active Expired - Lifetime
- 1997-05-12 HU HU9901620A patent/HU227745B1/hu unknown
- 1997-05-12 KR KR1019980701493A patent/KR19990044257A/ko active Search and Examination
- 1997-05-12 DE DE69726729T patent/DE69726729T2/de not_active Expired - Lifetime
- 1997-05-12 PL PL97330931A patent/PL188566B1/pl unknown
- 1997-05-12 PT PT97923915T patent/PT904060E/pt unknown
- 1997-05-12 DK DK97923915T patent/DK0904060T3/da active
- 1997-05-12 WO PCT/EP1997/002507 patent/WO1997044014A1/en active IP Right Grant
- 1997-05-12 SI SI9730613T patent/SI0904060T1/xx unknown
- 1997-05-12 CZ CZ19981885A patent/CZ293841B6/cs not_active IP Right Cessation
- 1997-05-19 TW TW086106621A patent/TW460282B/zh not_active IP Right Cessation
- 1997-05-19 AR ARP970102113A patent/AR007195A1/es not_active Application Discontinuation
- 1997-05-19 MY MYPI97002173A patent/MY123827A/en unknown
- 1997-05-19 ID IDP971648A patent/ID16926A/id unknown
- 1997-05-20 HR HR970270A patent/HRP970270B1/xx not_active IP Right Cessation
-
1998
- 1998-06-05 NO NO19982599A patent/NO320495B1/no not_active IP Right Cessation
- 1998-06-11 BG BG102532A patent/BG64368B1/bg unknown
- 1998-07-02 MX MX9805418A patent/MX9805418A/es active IP Right Grant
-
1999
- 1999-07-10 HK HK99102947A patent/HK1018002A1/xx not_active IP Right Cessation
-
2002
- 2002-08-14 US US10/218,851 patent/US7081255B2/en not_active Expired - Fee Related
-
2004
- 2004-03-29 CY CY0400023A patent/CY2434B1/xx unknown
-
2006
- 2006-06-01 US US11/445,849 patent/US8591948B2/en not_active Expired - Lifetime
-
2013
- 2013-11-01 US US14/069,842 patent/US9642806B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9706897A (pt) | Composições antifúngicas com biodisponibilidade aperfeiçoada. | |
HUP0203568A2 (hu) | Vírusellenes készítmények | |
FR2805818B1 (fr) | Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant | |
AR098808A2 (es) | Una forma de dosificación farmacéutica de fusión instantánea que se desintegrará en la boca en un tiempo de 25 segundos | |
BG104680A (en) | Celecoxib compositions | |
NO330947B1 (no) | Anvendelse av farmasoytiske sammensetninger som inneholder okskarbazepin, i fastende tilstand | |
EE200100010A (et) | Kinoliini derivaadid, nende kasutamine ravimina, neid sisaldavad farmatseutilised kompositsioonid ning ühendite ja farmatseutiliste kompositsioonide kasutamine patoloogilisest põletikust ja autoimmuunsusest tingitud haiguste ravis | |
CA2339991A1 (en) | Microemulsions as solid dosage forms for oral administration | |
FR2807038B1 (fr) | Nouveaux derives d'indolin-2-one, leur preparation et les compositions pharmaceutiques les contenant | |
DE69432559D1 (de) | Verwendung von eisenbindenden polymeren zur herstellung eines medikaments zur oralen verabreichung | |
CO5251419A1 (es) | Composiciones nanoparticuladas de eplerenona | |
BR0003158A (pt) | Formulação de dosagem oral de derretimentoinstantâneo | |
DE69919179D1 (de) | Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen | |
EE200100007A (et) | Kinoliini derivaadid, nende kasutamine ravimina, neid sisaldavad farmatseutilised kompositsioonid ning ühendite ja farmatseutiliste kompositsioonide kasutamine patoloogilisest põletikust ja autoimmuunsusest tingitud haiguste ravis | |
BR0014383A (pt) | Composições de liberação controlada compreendendo nimesulida | |
HUP0101411A2 (hu) | 2-es típusú angiotenzin II receptor agonistákat tartalmazó gyógyszerkészítmények és ezek alkalmazása | |
TR200200981T2 (tr) | Farmasötik bileşim terkipleri | |
EA200400357A1 (ru) | Дезинтегрирующиеся в ротовой полости композиции валдекоксиба | |
DE60116662D1 (de) | Hemmung von systemischen infektionen in menschen und wirbeltieren mit ballaststoffen | |
CA2317465A1 (en) | Synthetic polysaccharides, their method of production and pharmaceutical compositions containing same | |
PT866791E (pt) | Diaminopirimidinas formulacoes farmaceuticas que as contem e sua utilizacao antibacteriana | |
BR0314129A (pt) | Formulações de liberação modificadas de oxcarbazepina e derivados destas | |
HUP0402178A2 (hu) | 5 HT1 antagonista hatóanyagot tartalmazó gyógyszerkészítmény | |
FR2796380B3 (fr) | Nouveaux derives d'aminothiazoles, leur preparation et les compositions pharmaceutiques les contenant | |
MD970244A (en) | Dimer lysozime new application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PRESENTE PEDIDO, POR DESACORDO COM OS ARTIGOS 8O, 13 E 229-A DA LPI, LEI DE NUMERO 9.279 DE 14/05/1996, CUJO REDACAO FORA MODIFICADA PELA LEI 10.196/01, ATRAVES DE PUBLICACAO 9.2 NA RPI |
|
B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 21/09/2010, OBSERVADAS AS CONDICOES LEGAIS. |
|
B22O | Other matters related to patents and certificates of addition of invention: legal action concerning patent |
Free format text: INPI-52400.061573/2013 ORIGEM: JUIZO DA 013A VARA FEDERAL DO RIO DE JANEIRO PROCESSO NO 0132265-40.2013.4.02.5101 ACAO DE NULIDADE DAS PATENTES SUBMETIDAS AO MAILBOX (ART. 229, PARAGRAFO UNICO DA LPI); ALTERNATIVAMENTE, A DECRETACAO DA NULIDADE PARCIAL PARA CORRECAO DO PRAZO DE VIGENCIA; SUBSIDIARIAMENTE, CASO SE ENTENDA NAO SER O CASO DE NULIDADE, A CORRECAO DO ATO ADMINISTRATIVO PARA ADEQUACAO DA VIGENCIA DAS PATENTES. AUTOR: INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL - INPI REU:JANSSEN PHARMACEUTICA N.V, JOHNSON AND JOHNSON CONSUMER, NEUTROGENA CORPORATION, KEIKO OTSU LOUIS V. KIRCHHOFF. |
|
B21B | Extinction acc. art. 78, item ii - on waiver by the patentee, without prejudice to the rights of third parties |
Free format text: SOLICITADA ATRAVES DA PETICAO 860130007859, DE 21/11/2013 |